V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 20023753 | 20010091 | null | 60 | Neo-adjuvant (N) | 2013-09-21 | 2013-09-21 | FEC + DOCETAXEL | 02 | N | 20083929 | FEC + DOCETAXEL |
| 20023754 | 20010092 | 1.75 | 79 | Adjuvant (A) | 2016-07-09 | 2016-07-18 | FEC + DOCETAXEL | 02 | null | 20083939 | FEC + DOCETAXEL |
| 20023755 | 20010093 | 1.66 | 74.9 | Adjuvant (A) | 2013-04-19 | 2013-04-25 | FEC 100 + DOCETAXEL | 02 | null | 20083952 | FEC + DOCETAXEL |
| 20023756 | 20010094 | 1.64 | 95 | Adjuvant (A) | 2016-02-19 | 2016-02-19 | FEC + DOCETAXEL | 02 | N | 20083959 | FEC + DOCETAXEL |
| 20023757 | 20010094 | 1.64 | 83 | Adjuvant (A) | 2015-08-13 | 2015-08-13 | FEC 100 + DOCETAXEL | 2 | N | 20083959 | FEC + DOCETAXEL |
| 20023758 | 20010094 | null | null | Adjuvant (A) | 2016-04-23 | 2016-05-06 | FEC 100 + DOCETAXEL | N | N | 20083959 | FEC + DOCETAXEL |
| 20023759 | 20010095 | 1.7 | null | Adjuvant (A) | 2015-10-17 | 2015-11-06 | FEC + DOCETAXEL | N | N | 20083965 | FEC + DOCETAXEL |
| 20023760 | 20070806 | 1.54 | 73.6 | Adjuvant (A) | 2013-06-07 | 2013-06-21 | FEC + DOCETAXEL | 2 | N | 20083970 | FEC + DOCETAXEL |
| 20023761 | 20010096 | 1.53 | 116.6 | Adjuvant (A) | null | 2013-11-22 | FEC 100 + DOCETAXEL | N | N | 20083973 | FEC + DOCETAXEL |
| 20023762 | 20010096 | 1.65 | 73.9 | Not known (9) | 2016-06-02 | 2016-06-14 | FEC + DOCETAXEL | N | N | 20083973 | FEC + DOCETAXEL |
| 20023763 | 20010097 | 1.65 | 65 | Adjuvant (A) | 2016-05-08 | 2016-05-09 | FEC 100 + DOCETAXEL | 2 | N | 20083988 | FEC + DOCETAXEL |
| 20023764 | 20010097 | 1.72 | 87.5 | Adjuvant (A) | 2017-08-20 | 2017-09-11 | FEC + DOCETAXEL | N | N | 20083988 | FEC + DOCETAXEL |
| 20023765 | 20010097 | null | null | Adjuvant (A) | 2017-02-17 | 2017-03-04 | FEC 100 + DOCETAXEL | null | null | 20083988 | FEC + DOCETAXEL |
| 20023766 | 20010098 | 1.66 | 83.6 | Curative (C) | null | 2014-03-25 | FEC + DOCETAXEL | N | N | 20083998 | FEC + DOCETAXEL |
| 20023767 | 20010098 | 1.75 | 89 | Neo-adjuvant (N) | 2015-09-13 | 2015-09-21 | FEC + DOCETAXEL | N | N | 20083998 | FEC + DOCETAXEL |
| 20023768 | 20010098 | 1.63 | null | Curative (C) | 2015-07-15 | 2015-07-15 | FEC 100 + DOCETAXEL | 02 | N | 20083998 | FEC + DOCETAXEL |
| 20023769 | 20010099 | null | 49 | Adjuvant (A) | 2015-12-23 | 2016-01-06 | FEC + DOCETAXEL | null | N | 20084010 | FEC + DOCETAXEL |
| 20023770 | 20010099 | null | null | Adjuvant (A) | 2017-03-17 | 2017-04-14 | FEC + DOCETAXEL | N | N | 20084010 | FEC + DOCETAXEL |
| 20023771 | 20108378 | 1.73 | 103.1 | Adjuvant (A) | 2016-09-29 | 2016-11-19 | FEC 100 + DOCETAXEL | N | N | 20084014 | FEC + DOCETAXEL |
| 20023772 | 20108378 | 1.62 | 80.4 | Adjuvant (A) | 2017-10-19 | 2017-10-22 | FEC + DOCETAXEL | 02 | N | 20084014 | FEC + DOCETAXEL |
| 20023773 | 20108378 | 1.6 | null | null | 2015-12-03 | 2015-12-17 | FEC 100 + DOCETAXEL | N | N | 20084014 | FEC + DOCETAXEL |
| 20023774 | 20108378 | null | null | Adjuvant (A) | 2016-01-09 | 2016-01-23 | FEC + DOCETAXEL | null | null | 20084014 | FEC + DOCETAXEL |
| 20023775 | 20010100 | null | 93 | Adjuvant (A) | 2014-12-25 | 2015-01-12 | FEC 100 + DOCETAXEL | null | null | 20084027 | FEC + DOCETAXEL |
| 20023776 | 20070811 | null | null | Adjuvant (A) | null | 2017-09-28 | FEC + DOCETAXEL | null | null | 20084029 | FEC + DOCETAXEL |
| 20023777 | 20010101 | 0 | 59 | Adjuvant (A) | null | 2015-11-12 | FEC + DOCETAXEL | N | N | 20084031 | FEC + DOCETAXEL |
| 20023778 | 20010101 | 1.57 | 76.6 | Adjuvant (A) | 2013-10-06 | 2013-10-06 | FEC + DOCETAXEL | 02 | N | 20084031 | FEC + DOCETAXEL |
| 20023779 | 20010101 | 1.55 | 76 | Adjuvant (A) | 2014-12-18 | 2014-12-29 | CYCLOPHOSPHAMIDE + DOCETAXEL + EPIRUBICIN + FLUOROURACIL | 02 | null | 20084031 | FEC + DOCETAXEL |
| 20023780 | 20010101 | 1.7 | 114 | Disease modification (D) | 2014-01-16 | 2014-01-18 | FEC + DOCETAXEL | 02 | N | 20084031 | FEC + DOCETAXEL |
| 20023781 | 20010101 | 1.62 | 90.8 | Adjuvant (A) | 2015-09-25 | 2015-10-19 | CYCLOPHOSPHAMIDE + DOCETAXEL + EPIRUBICIN + FLUOROURACIL | 02 | N | 20084031 | FEC + DOCETAXEL |
| 20023782 | 20010102 | 1.67 | 66.4 | Neo-adjuvant (N) | 2014-09-17 | 2014-10-01 | FEC 100 + DOCETAXEL | 1 | N | 20084045 | FEC + DOCETAXEL |
| 20023783 | 20070813 | 1.62 | 137 | Adjuvant (A) | 2015-02-13 | 2015-02-26 | FEC + DOCETAXEL | 02 | N | 20084050 | FEC + DOCETAXEL |
| 20023784 | 20108380 | null | null | Adjuvant (A) | 2013-07-12 | 2013-07-21 | FEC + DOCETAXEL | 2 | N | 20084053 | FEC + DOCETAXEL |
| 20023785 | 20108380 | 1.72 | 80 | Adjuvant (A) | null | 2016-06-28 | FEC 100 + DOCETAXEL | N | N | 20084053 | FEC + DOCETAXEL |
| 20023786 | 20108380 | 1.73 | 78.1 | Not known (9) | 2015-11-02 | 2015-11-05 | CYCLOPHOSPHAMIDE + DOCETAXEL + EPIRUBICIN + FLUOROURACIL | 02 | N | 20084053 | FEC + DOCETAXEL |
| 20023787 | 20010103 | 1.69 | 68 | Adjuvant (A) | 2016-04-27 | 2016-04-27 | FEC + DOCETAXEL | 02 | N | 20084068 | FEC + DOCETAXEL |
| 20023788 | 20010104 | 1.77 | 84 | Adjuvant (A) | 2016-04-06 | 2016-04-10 | FEC 100 + DOCETAXEL | 2 | N | 20084073 | FEC + DOCETAXEL |
| 20023789 | 20010104 | 1.58 | 93.2 | Adjuvant (A) | 2013-11-21 | 2013-11-21 | FEC + DOCETAXEL | 02 | N | 20084073 | FEC + DOCETAXEL |
| 20023790 | 20010105 | 1.62 | 82.2 | Adjuvant (A) | 2016-03-16 | 2016-04-06 | FEC + DOCETAXEL | N | N | 20084083 | FEC + DOCETAXEL |
| 20023791 | 20010105 | 1.79 | 80 | Adjuvant (A) | 2015-06-07 | 2015-06-18 | FEC + DOCETAXEL | 02 | null | 20084083 | FEC + DOCETAXEL |
| 20023792 | 20010106 | 1.64 | 69 | Not known (9) | 2017-08-01 | 2017-08-16 | FEC 100 + DOCETAXEL | 2 | N | 20084089 | FEC + DOCETAXEL |
| 20023793 | 20010106 | 1.63 | 79.9 | Curative (C) | null | 2014-03-28 | FEC + DOCETAXEL | N | N | 20084089 | FEC + DOCETAXEL |
| 20023794 | 20010107 | null | 64 | Neo-adjuvant (N) | 2014-12-16 | 2014-12-16 | FEC + DOCETAXEL | 02 | N | 20084093 | FEC + DOCETAXEL |
| 20023795 | 20070817 | 1.68 | 65.5 | Adjuvant (A) | 2014-02-04 | 2014-02-24 | FEC 100 + DOCETAXEL | 02 | N | 20084094 | FEC + DOCETAXEL |
| 20023796 | 20010108 | 1.68 | 85.8 | Adjuvant (A) | 2016-06-19 | 2016-07-09 | FEC 60 OR 75 + DOCETAXEL | N | N | 20084099 | FEC + DOCETAXEL |
| 20023797 | 20070818 | 1.64 | 84.3 | Adjuvant (A) | 2017-08-10 | 2017-08-16 | FEC 100 + DOCETAXEL | N | null | 20084100 | FEC + DOCETAXEL |
| 20023798 | 20010109 | 1.59 | 74 | Adjuvant (A) | 2015-10-19 | 2015-10-28 | FEC + DOCETAXEL | 02 | N | 20084105 | FEC + DOCETAXEL |
| 20023799 | 20070819 | 1.66 | 84.2 | Neo-adjuvant (N) | 2014-05-24 | 2014-06-19 | FEC + DOCETAXEL | 02 | null | 20084112 | FEC + DOCETAXEL |
| 20023800 | 20010110 | 1.65 | 85 | Adjuvant (A) | 2014-01-08 | 2014-01-30 | FEC 100 + DOCETAXEL | N | N | 20084113 | FEC + DOCETAXEL |
| 20023801 | 20010110 | 1.65 | 76 | Neo-adjuvant (N) | 2016-11-27 | 2016-12-08 | FEC 100 + DOCETAXEL | N | N | 20084113 | FEC + DOCETAXEL |
| 20023802 | 20010110 | 1.65 | 69.2 | Adjuvant (A) | 2015-05-02 | 2015-05-10 | FEC + DOCETAXEL | 02 | N | 20084113 | FEC + DOCETAXEL |